Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis B, Chronic”

1,151 trials

Showing 20 of 1,151 results

Not applicableUnknownNCT04211805
What this trial is testing

Maternal Therapy With TAF Versus TDF to Prevent Vertical Transmission of Hepatitis B

Who this might be right for
Hepatitis B, ChronicPregnancy Related
New Discovery LLC 450
Large-scale testing (Phase 3)Study completedNCT00117676
What this trial is testing

Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 382
Testing effectiveness (Phase 2)Study completedNCT02646189
What this trial is testing

Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients

Who this might be right for
Hepatitis B, Chronic
Replicor Inc. 12
Not applicableStudy completedNCT03350074
What this trial is testing

HBV Envelope Proteins Variability on HBs Antigen Clearance Under Nucleos(t)Ide Analogue Therapy

Who this might be right for
Hepatitis B, Chronic
Central Hospital, Nancy, France 19
Not applicableStudy completedNCT01826760
What this trial is testing

Study of the Model to Predict 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver Failure

Who this might be right for
Acute-on-chronic Hepatitis B Liver Failure
Wenzhou Medical University 583
Early research (Phase 1)UnknownNCT03244085
What this trial is testing

Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis b
Qilu Pharmaceutical Co., Ltd. 18
Early research (Phase 1)Study completedNCT04629976
What this trial is testing

Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Nucorion Pharmaceuticals, Inc. 21
Post-approval studies (Phase 4)Study completedNCT01887275
What this trial is testing

A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Nanfang Hospital, Southern Medical University 439
Early research (Phase 1)Not Yet RecruitingNCT07342881
What this trial is testing

Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function

Who this might be right for
Chronic Hepatitis B Infection
Aligos Therapeutics 30
Not applicableActive Not RecruitingNCT05423834
What this trial is testing

Chronic Kidney Disease Progression in Chronic Hepatitis B Patients on Tenofovir Alafenamide (TAF) Versus Entecavir

Who this might be right for
Chronic Hepatitis B
Chinese University of Hong Kong 1,800
Not applicableStudy completedNCT01471535
What this trial is testing

HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon Treated

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 20
Early research (Phase 1)Study completedNCT01671787
What this trial is testing

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 51
Large-scale testing (Phase 3)Study completedNCT01237496
What this trial is testing

Analysis of HBV-Specific Immune Response in Patients With HBeAg Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a (40KD)) - Immunology Sub-Study of ML18253

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 17
Not applicableStudy completedNCT03577938
What this trial is testing

Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment

Who this might be right for
Acute on Chronic Liver FailureTraditional Chinese MedicineHepatitis B
Beijing 302 Hospital 516
Not applicableStudy completedNCT02743182
What this trial is testing

HBsAg Loss Adding Pegylated Interferon in HBeAg-negative Patients

Who this might be right for
Chronic Hepatitis B (HBeAg-negative)
José Antonio Carrion 119
Large-scale testing (Phase 3)Study completedNCT05115942
What this trial is testing

Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.

Who this might be right for
Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 248
Early research (Phase 1)Study completedNCT04536337
What this trial is testing

ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

Who this might be right for
Chronic Hepatitis B
Aligos Therapeutics 165
Early research (Phase 1)Study completedNCT01353742
What this trial is testing

Lamivudine and Adefovir Dipivoxil Fixed Dose Combination

Who this might be right for
Hepatitis B, Chronic
GlaxoSmithKline 40
Testing effectiveness (Phase 2)Ended earlyNCT02604212
What this trial is testing

A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B
Arrowhead Pharmaceuticals 32
Early research (Phase 1)Ended earlyNCT05561530
What this trial is testing

ALG-125755 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single Doses in Healthy Volunteers, and Single and Multiple Doses in CHB Subjects

Who this might be right for
Chronic Hepatitis B
Aligos Therapeutics 57
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation